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GlutamateRecent studies at high ﬁeld (7 Tesla) have reported smallmetabolite changes, in particular lactate and glutamate
(below 0.3 μmol/g) during visual stimulation. These studies have been limited to the visual cortex because of its
high energymetabolism and goodmagnetic resonance spectroscopy (MRS) sensitivity using surface coil. The aim
of this study was to extend functional MRS (fMRS) to investigate for the ﬁrst time themetabolite changes during
motor activation at 7 T. Small but sustained increases in lactate (0.17 μmol/g ± 0.05 μmol/g, p b 0.001) and glu-
tamate (0.17 μmol/g ± 0.09 μmol/g, p b 0.005) were detected during motor activation followed by a return to
the baseline after the end of activation. The present study demonstrates that increases in lactate and glutamate
during motor stimulation are small, but similar to those observed during visual stimulation. From the observed
glutamate and lactate increase, we inferred that these metabolite changes may be a general manifestation of
the increased neuronal activity. In addition, we propose that the measured metabolite concentration increases
imply an increase in ΔCMRO2 that is transiently below that of ΔCMRGlc during the ﬁrst 1 to 2 min of the
stimulation.
© 2014 Elsevier Inc. All rights reserved.Introduction
Functional MR spectroscopy (fMRS) provides direct insights into
brain metabolism by investigating the metabolic response of the brain
to a physiological stimulus. The high spectral resolution and signal-to-
noise ratio (SNR) of fMRS at high ﬁeld (N3 Tesla) improve the accuracy
and precision of the quantiﬁcation of many brain metabolites (MekleCMR; CRLB, Cramér–Rao lower
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elich.de (A.W. Magill),et al., 2009; Tkac et al., 2001, 2009). In addition to the increased chem-
ical shift dispersion, a high time resolution is of advantage for the char-
acterization of the small transient changes observed. Recent fMRS
studies (Lin et al., 2012; Mangia et al., 2007b; Schaller et al., 2013) at
high ﬁeld (7 Tesla) reported small metabolite concentration changes
during visual stimulation (around 0.2 μmol/g). In particular, a very
small lactate concentration increase between 10 and 23% has been ob-
served. Recently, functional diffusion-weighted MRS has been used to
investigate metabolite ADC changes as a potential consequence of
micro structural changes during activation (Branzoli et al., 2013).
The lactate increase observed during visual stimulation has been
suggested to explain the mismatch of cerebral metabolic rate of change
for glucose (ΔCMRGlc) (or cerebral blood ﬂow, CBF) and cerebral meta-
bolic rate of change for oxygen (ΔCMRO2) during brain activation. How-
ever, many studies have reported different results concerning the
transient mismatch of ΔCMRGlc, CBF and ΔCMRO2 during functional ac-
tivity (reviewed in Buxton (2010)). The characterization of these chang-
es has been reported in positron emission tomography (PET) (Fox and
Raichle, 1986; Fox et al., 1988; Fujita et al., 1999; Marrett and Gjedde,
1997; Vafaee and Gjedde, 2000) and in MR studies (Chen et al., 1993,
2001; Davis et al., 1998; Hoge et al., 1999; Kim and Ugurbil, 1997; Kim
et al., 1999; Lin et al., 2010; Liu et al., 2004; Vafaee et al., 2012; Wey
139B. Schaller et al. / NeuroImage 93 (2014) 138–145et al., 2011), and their differences have been attributed to different
experimental conditions and the brain region examined (Buxton,
2010; Rothman et al., 2003; Vafaee and Gjedde, 2000, 2004; Zhu et al.,
2009). Nevertheless, an energy balance calculation suggests that the en-
ergydemands during visual activation are largelymet through oxidative
metabolism at all times (Mangia et al., 2007a).
A positive BOLD signal appears to be a universal hallmark of physio-
logical brain activation and has been suggested to depend on a mis-
match ratio between cerebral blood ﬂow change (ΔCBF) and ΔCMRO2,
the magnitude of which remains undetermined (reviewed in Buxton
(2010)). Metabolite changes detected with fMRS likely reﬂect changes
through oxidative and non-oxidative pathways.
Therefore, the aim of this study was to determine the metabolite
changes occurring during motor activation in the human brain and to




Eleven healthy subjects (9 men and 2 women aged 18 to 26 years,
right-handed) were enrolled in the fMRS study. One additional subject
was used in a preliminary study to investigate the effect of the dielectric
pad. All the subjects gave informed consent according to the procedure
approved by the local ethics committee. The experiments were
performed on a 7 T/68 cm scanner (Siemens, Erlangen, Germany)
with the use of a single-channel quadrature transmit (physical z length
~180 mm) and 32-channel receive coil (Nova Medical Inc., MA, USA).
Dielectric pad
A single MR-invisible dielectric pad was constructed as speciﬁed in
Teeuwisse et al. (2012a). The pad measured 100 × 100 × 5 mm3 and
was ﬁlled with a solution of deuterated water and barium titanate (di-
electric permittivity of 160). The dielectric pad was placed directly on
the subject's head, above the central sulcus of the left hemisphere. Full
wave electromagnetic simulations were executed with Microwave Stu-
dio (CST, Darmstadt, Germany) to study the RF ﬁeld distribution and the
corresponding SAR maps. The simulated coil was loaded with a human
headmodel (Duke from the Virtual Family (Christ et al., 2010)) and run
with and without the dielectric pads present (same position as in the
fMRS experiment). Subsequently, B1+ maps were acquired for one vol-
unteer using the SA2RAGE sequence (TR = 2400 ms, TE = 0.78 ms,
TD1= 45ms, TD2= 1800ms,α1 = 4°,α2 = 10°, 2 × 2 × 2.5 mm3 res-
olution and a 128 × 128 × 64matrix size acquired with sagittal orienta-
tion, TA= 1min 55 s, reference voltage= 170 V) (Eggenschwiler et al.,
2011), with and without the dielectric pad present.
Activation paradigm
During the functional MRS runs, the subject was asked to execute a
cued ﬁnger-to-thumb tapping task with both hands at a frequency of
3 Hz. Subjects were asked to execute a demanding motor task at a
ﬁnger-tapping rate of 3 Hz, which elicits the highest changes for CBF
(which occurs in parallel to CMRGlc (Gjedde et al., 2002; Paulson et al.,
2010)) and CMRO2 in the primary motor cortex (Vafaee and Gjedde,
2004). The tip of each ﬁnger was applied twice to the thumb for each
hand. The bilateral ﬁnger-to-thumb movement was repeated during
the entire activation period. Numbers from 1 to 4 (one number was as-
sociated to each ﬁnger) were projected on a screen at the back of the
scanner to provide the visual cue. During the rest period, the subject
was asked to keep his hands in the same position (palms open) and
not to move his ﬁngers. Proper understanding and good performance
of the activation paradigm (rate, amplitude and intensity of the ﬁnger-
tapping) was guaranteed by a practice session outside the scannerbeforehand.While performing the task in the scanner during the exper-
iment, subject's performance was carefully monitored. Foam padding
was placed around the head of the participants to ensure the subject's
comfort and to minimize motion. During the fMRS measurement, each
subject performed the motor task with the following timing: four alter-
nate periods of 5 min of motor activation and rest (ON–OFF–ON–OFF),
preceded by a 2 min rest period (22 min total duration).
MR protocol
Anatomical images were acquired using MP2RAGE (Marques et al.,
2010) (TR = 5500 ms, TE = 2.84 ms, TI1 = 750 ms, TI2 = 2350 ms,
α1 = 4°, α2 = 5°, 1 × 1 × 1 mm3 resolution, 256 × 256 × 176 matrix
size acquired with sagittal orientation and TA = 7 min 20 s). A
“localizer” fMRI experiment was performed (20 s ON, 20 s OFF, total ac-
quisition time of 2 min 30 s, previously described motor task) using a
multi-slice EPI sequence similar to the one described in van der Zwaag
et al. (2009). The overlap of the activation map on the anatomical im-
ages guided the placement of the voxel of interest (VOI) for the subse-
quent fMRS scans. The VOI was placed in an area of high motor
activation, covering the hand area of the motor and the somatosensory
cortices (inset in Fig. 3). First- and second-order shims were adjusted
using FAST(EST)MAP (shim volume = 22 × 25 × 22 mm3) (Gruetter,
1993; Gruetter and Tkac, 2000). Flip angles of the water suppression
pulses were optimized to reduce the residual water peak height below
that of NAA. In addition, OVS bands were carefully placed to suppress
signal from outside the VOI, in particular extra cerebral fat signal. 1H
MR spectra were continuously acquired during the functional task
using the semi adiabatic SPECIAL sequence (TR/TE = 7500/12 msec,
bandwidth = 4000 Hz, vector size = 2048 pts, VOI = 17 × 20 ×
17 mm3, NT = 88 × 2) (Xin et al., 2012) preceded by VAPOR water
and outer volume suppression (Tkac and Gruetter, 2005).
Data processing
Free induction decay (FID) signals were acquired for each pair of
scans (NT=2). The individual 1HMR spectra were frequency corrected
using home-written Matlab (Mathworks, Natick, MA, USA) routine to
compensate for small B0 drift (Tkac and Gruetter, 2005) by aligning
the creatine peak (3.03 ppm) of 1H MR spectra. 1H MR spectrum time
courses were ﬁrst analyzed in single subjects by averaging spectra in
blocks of 4 spectra. To validate the metabolite changes, a paired two-
tailed student t-test was performed based on the individual time
courses of each subject. In a second approach (group analysis), FIDs
were averaged over the eleven subjects in blocks of 22 1H MR spectra
(2 spectra per subject, n = 11). A moving average with kernel of 4
points was used to plot the time courses.
To further validate the observedmetabolite changes, the 1HMR spec-
tra from the last 3.75 min of each period were summed separately
between activation (NT = 56, n = 11) and rest (NT = 56, n = 11) and
then subtracted to yield a difference spectrum. To validate the statistical
signiﬁcance of the metabolite changes, a paired two-tailed student
t-test was performed using the quantiﬁcation of the aforementioned
summed activation spectra and the summed rest spectra for each subject.
Metabolite changes with p-values below 0.05 were considered to be
statistically signiﬁcant. The transition time of the hemodynamic response
at the beginning of a period (rest or activation) was not considered, nei-
ther for the statistical analyses, nor for the difference spectrum, as theme-
tabolites had not reached yet their respective new steady state. The BOLD
effect correction of the difference spectrum was performed by applying
an additional line-broadening (lb = 0.25 Hz) to the summed activation
spectra. The correction implied the minimization of the Cr (3.03 ppm)
and NAA (2.01 ppm) resonances in the difference spectrum.
All 1H MR spectra and difference spectra were ﬁtted and quantiﬁed
using LCModel (Provencher, 1993) with a basis set of simulated spectra
of 20 metabolites using published values for chemical shift and
140 B. Schaller et al. / NeuroImage 93 (2014) 138–145J-coupling (Govindaraju et al., 2000; Xin et al., 2008). A macromole-
cule signal measured in predominantly gray matter was also includ-
ed in the basis set. The LCModel analysis was carried out from 0.2 to
4.2 ppm. A creatine concentration of 8 μmol/g was assumed for the
scaling of the metabolite concentrations. Only metabolites with
Cramér–Rao lower bounds (CRLB) below 30% were used for statisti-
cal analysis (NT = 56) and for the group analysis (NT = 22). For the
individual time courses (NT = 4), lactate and glutamate were quan-
tiﬁed with CRLB below 40%.
Results
To mitigate the limitations imposed on B1+, a dielectric pad was
placed above the central sulcus (left hemisphere) in order to shift the
B1+ “hot spot” towards the area of interest at the expense of decreasing
the B1+ intensity in the lower parts of the brain (frontal lobe and visual
cortex). Simulations of the RF ﬁeld distribution were run without and
with the pad present (data not shown) and no increase of the peak
local 10 g-averaged SAR was observed, in agreement with previous re-
ports (Snaar et al., 2011; Teeuwisse et al., 2012a,b).
To investigate the beneﬁt of using a dielectric pad, B1+mapswere ac-
quired with one volunteer without and with the pad present (Fig. 1A,
left andmiddle images). The presence of the pad enabled a B1+ sensitiv-
ity gain up to 50% in the area of interest under investigation on B1+maps
(Fig. 1A, right).
First- and second-order shims resulted in typical water linewidths of
12.6 ± 0.8 Hz (mean ± SD, n = 11). Stable and reproducible 1H MR
spectra with negligible lipid contamination were acquired during theFig. 1. (A) Improved transmit B1 for localized MRS using a dielectric pad (red bar in the
middle image). Measured B1+ maps without (left) and with (middle) the dielectric pad
present. The ratio of the two images (right) shows a B1+ increases up to twice in the area
of interest (black square), above which the pad was placed. The scale of the B1+ maps,
obtained using SA2RAGE sequence (Eggenschwiler et al., 2011) corresponds to amultipli-
cative factor of a desired ﬂip angle. (B) Representative 1HMR spectra acquired with semi-
adiabatic SPECIAL sequence (TR/TE = 7500/12 ms, bandwidth = 4000 Hz, vector size =
2048 pts, VOI = 17 × 20 × 17 mm3, NT = 22) and the dielectric pad. 8 metabolites were
reliably quantiﬁed with LCModel with CRLB below 10%: creatine (Cr), phosphocreatine
(PCr), glutamine (Gln), glutamate (Glu), myo-inositol (Ins), N-acetylaspartate (NAA),
N-acetylaspartylglutamate (NAAG) and total choline (tot Cho); 5 metabolites with CRLB
below 20%: aspartate (Asp), γ-aminobutyrate (GABA), glutathione (GSH), lactate (Lac),
and taurine (Tau); and 1 metabolite with CRLB less than 30%: and Phosphoethanolamine
(PE).fMRS experiment (Fig. 1B) and the SNR of N-acetylaspartate (NAA) res-
onance was typically 57 ± 5 (mean ± SD, n = 11) for a pair of scans.
The water signal was generally minimized below the height of the
NAApeak and no signal contamination, due to extraneous lipid, was ob-
served in the spectral region 1–2 ppm.
To determine that the placement of the VOI minimized partial vol-
ume effect, the inﬂuence of the physiological activation on the 1H MR
spectra linewidth was investigated. In particular, the creatine peak
height was measured to assess the metabolite BOLD effect. Linewidth
narrowing of the 1H MR spectra, which is induced by the BOLD effect
(Zhu and Chen, 2001), was observed during the time course (data not
shown) and resulted in a mean increase of the creatine peak height of
2% during activation periods (n = 11).
To investigate the metabolite changes for individual subjects, the 1H
MR spectra were ﬁrst averaged in blocks of 4 spectra. Lactate (Lac) and
glutamate (Glu) were quantiﬁed with CRLB below 40% and 5%, respec-
tively. The mean variation of the Lac and Glu concentrations of the
averaged time courses was below 0.05 μmol/g and 0.07 μmol/g, respec-
tively, for both periods (rest and activation), well below the observed
metabolite increases. Statistically signiﬁcant increases of Lac by 17 ±
5% (0.17 ± 0.05 μmol/g, p b 0.001, n = 11) and of glutamate (Glu) by
2± 1% (0.17± 0.09 μmol/g, p b 0.005, n= 11)were foundwhen com-
paring the quantiﬁcation of the summed activation spectra to the
summed rest spectra (NT = 56 for given activation and rest periods)
(Table 1). No other metabolite changes reached statistical signiﬁcance.
To analyze the metabolite changes, 1H MR spectra were averaged
between the subjects by blocks of 22 spectra (group analysis, n = 11),
which enabled a native time resolution of 15 s for the metabolite
time courses (Fig. 2A). The averaged 1H MR spectra allowed quan-
tiﬁcation of 8 metabolites with CRLB less than 10% (creatine, phospho-
creatine, glutamine, glutamate, myo-inositol, N-acetylaspartate,
N-acetylaspartylglutamate and total choline), 5 metabolites with CRLB
less than 20% (aspartate, ϒ-aminobutyrate, glutathione, lactate, and
taurine) and 1 metabolite (Phosphoethanolamine) with CRLB less
than 30%. Note that the plots with themoving average (Fig. 2B) indicat-
ed that a steady state was reached by Lac and Glu within the ﬁrst
1–2 min of activation.
To conﬁrm the observed metabolite changes, a difference spectrum
was obtained by subtracting the summed rest spectra (NT = 56, n =
11) to the summed activation spectra (NT = 56, n = 11) (Figs. 3A–C).
The linewidth narrowing caused by the BOLD effect was clearly visible
in the difference spectrum at the singlet resonances of Cr (3.03 ppm)
and NAA (2.01 ppm). Therefore, an additional line-broadening of 0.25
Hz was applied to the summed spectra acquired during activation to
correct for the linewidth narrowing, resulting in a detectable Glu and
Lac increases at 2.1/2.3/3.7 ppm and 1.3/4.1 ppm, respectively
(Fig. 3D). LCModel quantiﬁcation of the corrected difference spectrum
provided Lac and Glu increases of 0.19 ± 0.01 μmol/g and 0.10 ±
0.01 μmol/g (concentration ± CRLB), respectively (Fig. 3E).Table 1
Mean lactate (Lac) and glutamate (Glu) concentrations during the rest or activation
periods and the concentration changes during the functional paradigm. Only Lac and
Glu changes were signiﬁcant (p b 0.05, paired two tailed t-test). The mean concentration
for the rest and activation periods (μmol/g) were obtained from the summed activation
and rest spectra (NT=56 scans for rest and for activation periods, n= 11). Concentration
changes are expressed in absolute concentration (μmol/g) or in percentage (%). Data are












Lac 1.02 ± 0.03 1.20 ± 0.03 0.17 ± 0.05 17 ± 5
Glu 10.25 ± 0.06 10.41 ± 0.06 0.17 ± 0.09 2 ± 1
Fig. 2. (A) Group analysis shows the time courses of Lac and Glu during the functional paradigmwith a time resolution of 15 s. Each time point is the averaged of 22 1HMR spectra (2 scans
per subject, n = 11). (B) A moving average was applied after quantiﬁcation (moving average kernel of 4 scans). Data are reported as mean ± s.e.m. in μmol/g.
Fig. 3. Summed 1H spectrum acquired during activation (A) and rest (B) periods (NT= 56,
n=11). Subtraction of the summed rest spectra to the summed activation spectra provided
the difference spectrum (C). An additional line broadening (*) of 0.25 Hzwas applied to the
summed activation spectra to correct for the BOLD effect on metabolite linewidth (D).
LCModel quantiﬁcation of the corrected difference spectrum (E) yielded a Lac and Glu in-
crease of 0.19±0.01 μmol/g and 0.10±0.01 μmol/g (concentration± CRLB), respectively.
A linebroadeningof 1Hzwas applied to all the 1HMR spectra. Inset: Overlap of the anatom-
ical image and the activationmap. The location of the VOI (17 × 20× 17mm3) covering the
motor and somatosensory cortices is indicated by a red square.
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This study reports metabolite changes in the human brain during
motor activation. A lactate increase of 17 ± 5% (p b 0.001) and a gluta-
mate increase of 2 ± 1% (p b 0.005) were observed during the activa-
tion periods (Table 1). The magnitude of the observed metabolite
changes is comparable to previous reports performed in the visual cor-
tex (Lin et al., 2012; Mangia et al., 2007a; Schaller et al., 2013).
The use of the semi adiabatic SPECIAL sequence (Xin et al., 2012) at
7 T and thedielectric pad (Fig. 1A) yielded sufﬁcient sensitivity to inves-
tigate the metabolite changes during motor activation, as judged from
CRLB of Lac and Glu with CRLB b 12% and 2% (NT = 22), respectively
(Fig. 1B). Based on the fMRI “localizer” experiment, the VOI was placed
in an area of intensemotor activation. 1HMR spectrawere devoid of any
potential lipid contamination in the region 1–2 ppm. The increase of the
creatine peak height (approximately 2%) during the activation periods
gave evidence that the VOI was placed in the activated area (data not
shown). From the individual times courses, lactate increases were no-
ticeable in each subject, but the change was more apparent when aver-
aging across all subjects. In addition to Lac, a Glu increase was also
observed during activation and both increases were conﬁrmed by the
group analysis (Fig. 2). The plots of the metabolite changes of the
group analysis clearly illustrated a new steady state reached by theme-
tabolites. These observations and the magnitude of the changes were
comparable to those reported by previous studies during visual stimula-
tion at 7 T (Lin et al., 2012; Mangia et al., 2007b; Schaller et al., 2013).
LCModel quantiﬁcation of the difference spectrum (Fig. 3), corrected
for the BOLD narrowing of the linewidth during activation, yielded Lac
and Glu increases, which were consistent with the metabolite changes
observed in the group analysis.
A lactate increase of 0.17± 0.05 μmol/g (p b 0.001, n= 11)was ob-
served uponmotor stimulation in this study and a new steady state was
reached within the ﬁrst minutes of activation (Fig. 2). As discussed by
Mangia et al. (2007a), the increase in Lac, which implies an increase in
pyruvate (Pyr) (because of the dynamic equilibrium between Lac and
Pyr),may sustain the increased ﬂux into the oxidative pathway by stim-
ulating the activation of pyruvate dehydrogenase (Hawkins et al.,
Fig. 4. Proposed scheme illustrating changes of glucose consumption (ΔCMRGlc) asso-
ciated with the observed metabolite changes of Lac and Glu (red*) occurring during neu-
ronal motor activation. Lactate (Lac) increase is generated by anaerobic glycolysis
(A) whereas glutamate (Glu) changes may be achieved through pyruvate carboxylation
(PC), a reaction requiring oxygen consumption (B). A total increase of the glucose con-
sumption, ΔCMRGlc(tot), of 40–50% and relative increase of oxygen consumption (from
ATP consideration), ΔCMRO2, of 8% were inferred from the initial rise of Lac and Glu time
courses (see Discussion). G3PDH, glyceraldehyde-3-phosphatedehydrogenase; LDH, lac-
tate dehydrogenase; PDH, pyruvate dehydrogenase; ICDH, isocitrate dehydrogenase;
GDH, glutamate dehydrogenase, 2-OG, alpha-ketoglutarate.
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and Lac efﬂux to the blood, as suggested by (Mangia et al. (2007a).
Many studies have reported different lactate changes in the two last
decades during visual activation: an increase of 10–250% (Frahm et al.,
1996; Prichard et al., 1991; Sappey-Marinier et al., 1992) or the absence
of changes (Boucard et al., 2005; Merboldt et al., 1992; Sandor et al.,
2005). Kuwabra et al. reported a large lactate increase during motor
stimulation in the basal ganglia at 1.5 T (mean increase of Lac/Cr of
0.2) (Kuwabara et al., 1995). In addition to an optimized methodology,
increases of chemical shift dispersion, spatial and temporal resolutions
at high ﬁeld are crucial for an accurate and reliable quantiﬁcation of
the metabolite changes. Recent studies, performed at 7 T (Lin et al.,
2012;Mangia et al., 2007a; Schaller et al., 2013), reported consistent in-
creases of lactate during visual stimulation (10–20%). However, in con-
trast to Lin et al., which showed a transient increase of Lac during
activation, both Mangia et al. (2007a) and Schaller et al. (2013)
observed an increase of Lac to a new steady state within the ﬁrst
1–2min of visual activation similar to that observed in this study during
motor activation.
Additionally, an increase of Glu of 0.17 ± 0.09 μmol/g (p b 0.005,
n = 11) was observed during the motor activation similar to that was
detected in visual stimulation (Schaller et al., 2013). Several factors
have been suggested to explain the Glu changes during activation
(reviewed in Mangia et al. (2012)) such as an increased ﬂux through
the malate–aspartate shuttle (Mangia et al., 2007a; McKenna et al.,
2006), increased Glu/Gln cycling, or GSH synthesis (Lin et al., 2012). In
addition to the Asp decrease already reported by Mangia et al., and Lin
et al. reported a signiﬁcant change for GSH, which may support these
hypotheses. However, neither Asp nor GSH signiﬁcantly changed in
our study. Therefore, the Glu change observed was likely generated by
increased ﬂux through pyruvate carboxylase (Oz et al., 2004) and via
glutamate dehydrogenase (McKenna et al., 2000) (Fig. 4B).
Unlike Mangia et al. (2007a) and Lin et al. (2012), Glc and Asp con-
centration changeswere not signiﬁcant in this study and no trendswere
observed on the time courses.
It is of interest to note that the lactate increase observed during
motor activation (17 ± 5%) was similar to that observed during visual
activation (19 ± 4%) (Schaller et al., 2013). However, the Glu change
was halvedwhen comparing themotor activation (2±1%) to the visual
activation (4 ± 1%). Meanwhile, motor activation also led to a similar
reduction in BOLD response as detected with the creatine peak height
percentage change (2% in the motor activation versus 3% in the visual
activation) and by the BOLD effect correction applied to the summed ac-
tivation spectra (line broadening of 0.25 Hz in themotor activation ver-
sus 0.45 Hz in the visual activation (Schaller et al., 2013)). While a
proportional relationshipmay exist between the increased ﬂux through
oxidative pathways and change in BOLD response (Davis et al., 1998;
Hoge et al., 1999; Lin et al., 2010), this also suggest that partial volume
effect might lead to reduced Glu changes, even though a small VOI
(17 × 20 × 17 mm3) was used in this study.
Although Mangia et al. (2007a) concluded from similar lactate in-
crease that energy demands at steady state are nearly completely
matched by oxidative energy metabolism, they also noted that this
may not be the case throughout the entire time course. The small in-
crease in glutamate and lactate likely imply a small transient mismatch
of glucose and oxygen metabolic rates, as they represent an increment
in carbons in tissue (not being oxidized).
In the following,we provide an estimate of implied CMRO2 and CMR-
Glc changes noting that the relative change in CMRGlc over CMRO2 may
very well be smaller, as the changes may not account for all CMR02
changes.
Changes in glucose (ΔCMRGlc(tot)) and oxygenmetabolism (ΔCMRO2)
can be inferred from the initial rise of lactate and glutamate, as follows:
we estimate that steady-state levels of lactate and glutamate are reached
approximately 1.5 min after onset of stimulation, resulting in a net in-
crease of carbon in tissue, otherwise metabolized to CO2. The rate oflactate increase thus amounts to approximately 0.11 μmol/g/min, which
corresponds to a non-oxidative glucose consumption, ΔCMRGlc,non-ox, of
approximately 0.06 μmol/g/min by glycolysis (Fig. 4A). The glutamate
rate increase by approximately 0.11 μmol/g/min is likely the result of
increased ﬂux through pyruvate carboxylase (PC) (Oz et al., 2004),
which in turn implies an oxidative glucose consumption, ΔCMRGlc,ox,
of 0.11 μmol/g/min to complete a 6-carbon molecule (citrate)
(Fig. 4B). Thus, the total increase of glucose consumption during the
stimulation, ΔCMRGlc(tot), was estimated at 0.17 μmol/g/min, which
corresponds to a 40–50% increase from the basal state of CMRGlc
(0.34–0.42 μmol/g/min (Alkire et al., 1999; Huisman et al., 2012)). It
is of interest to note that such estimatedΔCMRGlc(tot) is close toΔCBF re-
ported in previous PET studies during motor stimulation (Ito et al.,
2005) or somatosensory stimulation (Fox and Raichle, 1986), but
ΔCMRGlc(tot) may actually exceed the estimated value due to incremen-
tal CMRO2 not accounted for by this calculation.
To determine the relative increase of ΔCMRO2 during activation, the
contribution of the ATP production coupled tomitochondrial oxidation,
143B. Schaller et al. / NeuroImage 93 (2014) 138–145relative to the glucose used for glutamate synthesis (ΔCMRGlc,ox =
0.11 μmol/g/min) was evaluated: not all glucose that enters the TCA
cycle from pyruvatewill be completely oxidized and thuswill not deliv-
er 36 ATPs per glucose from the produced NADH and FADH2, which can
be seen as follows: the synthesis of one citrate from oxaloacetate (OAA)
and Acetyl-CoA requires 2 molecules of pyruvate (1 through PC and 1
through pyruvate dehydrogenase) (Fig. 4B). The produced NADH is ox-
idized via the electron transport chain and hence energy results in ATP
synthesis. The synthesis of glutamate from glucose produces 8 ATPs in-
stead of the 36 ATPs for complete oxidation of glucose, thereby consum-
ing considerably less O2 per glucose molecule (i.e. 8/36 of O2 normally
required for complete glucose oxidation). When assuming a near-
complete oxidation of glucose at rest (Siesjo, 1978), the oxidation of
ΔCMRGlc,ox leading to glutamate increase corresponds to ΔCMRO2 of
5.5 × ΔCMRGlc,ox × 8/36 = 0.14 μmol/g/min, which amounts to a rela-
tive ΔCMRO2 increase of 10% (given a basal state of 1.5 μmol/g/min
(Ito et al., 2005)). Note that this incremental ΔCMRO2 is close to the re-
ported CMRO2 increase in motor stimulation (Ito et al., 2005) and so-
matosensory stimulation (Fox and Raichle, 1986). In addition, a recent
study by Vafaee et al. (2012) reported a ΔCMRO2 ~6% after 1 min of ﬁn-
ger tapping activation in M1 motor area.
The phosphocreatinepool is a high energy reserve in thebrain.How-
ever, with the high number of ATP produced per glucose molecule, the
effect of a 10% PCr reduction in theﬁrstminute (which is possiblewithin
experimental error), results in approximately 0.3 μmol/g/min ATP pro-
duced (given a basal state of 0.3 μmol/g/min (Mekle et al., 2009)), a
quantity that is negligible in the overall energy budget.
It is important to stress that the estimated changes in ΔCMRGlc and
ΔCMRO2 were calculated by neglecting any concomitant increase in
ΔCMRGlc,ox not detected by the metabolite changes. However, such an
additional increment in ΔCMRGlc,ox does not alter the conclusion of a
transient mismatch, as can be seen from the following example: adding
a 10% increase in ΔCMRGlc and ΔCMRO2 yields a ΔCMRGlc(tot) of 50–60%
and a ΔCMRO2 of 20%. Note, however, that it is equally likely that in-
creasedmetabolism during activation results in an increase of glycolytic
and TCA cycle intermediates, derived from glucose and thus not
completely oxidized.
Therefore, within the experimental errors of the present study, the
metabolic changes in the ﬁrst minutes imply a transient drop in
oxygen–glucose index (OGI), deﬁned as the molar ratio of oxygen con-
sumption to glucose utilization CMRO2/CMRGlc (OGI = 6 if glucose is
completely oxidized). It is thus plausible that the measured changes
mainly represent the metabolic events during the ﬁrst minutes of the
PET studies, given the characteristics of the bolus-shaped arterial input
function of PET FDG studies and the short half-life of 2 min of 15O (Fox
and Raichle, 1986; Ito et al., 2005). Therefore, these considerations
offer an explanation to the apparent discrepancy between the steady-
statemeasurements byNMR implying a near complete oxidation of glu-
cose during activation (Lin et al., 2012; Mangia et al., 2007a; Schaller
et al., 2013) and PET (Fox and Raichle, 1986; Ito et al., 2005).
Nevertheless, numerous studies have reported different experimen-
talmeasurements ofΔCBF/ΔCMRO2mismatch in humanbrain (reviewed
in Buxton (2010); Hyder (2004); Hyder and Rothman (2012)). The orig-
inal ΔCBF/ΔCMRO2 ~6 reported by Fox and Raichle (Fox and Raichle,
1986) is generally higher than other human brain PET studies (Hyder,
2004; Ito et al., 2005; Kuwabara et al., 1992; Marrett and Gjedde,
1997). For calibrated BOLD-measurement studies, the ratio ΔCBF/
ΔCMRO2 generally lies from 2 to 4 (Buxton, 2010). In animal studies,
large CMRO2 and CBF changeswere observed during sensory stimulation
in anesthetized rats (reviewed inHyder and Rothman (2012)). Addition-
ally, 13C MRS studies (in animal and human) allows the correlation be-
tween neuronal glucose oxidation and neuronal activity, and revealed
high oxidative metabolism demand during neuronal activation (Chen
et al., 2001; Chhina et al., 2001; Hyder et al., 1996, 1997). In vivo 17O
NMR may also be used to directly and non-invasively determine
CMRO2 (Mateescu, 2003; Zhu and Chen, 2011; Zhu et al., 2005) withhigh reliability and reproducibility (Zhu et al., 2007), aswell as the simul-
taneous in vivomeasurements of CBF (Zhu et al., 2013), whichmay help
unraveling the role of oxidative metabolism during functional activity.
These human and animal studies suggest that the mismatch ratio
and general glucose metabolism may depend on many criteria such
as: age of the subject (Kalpouzos et al., 2009; Nelhig, 1997), brain re-
gions, methodology, stimulus frequency (Vafaee and Gjedde, 2000;
Vafaee et al., 1999) and duration (Herman et al., 2009; Mintun et al.,
2002), basal metabolic status (Shen et al., 2008; Sicard and Duong,
2005) and the use of anesthesia (Austin et al., 2005; Dienel, 2012; Kim
et al., 2010). Finally, (Dienel, 2012) reviewed that different stimulus
paradigm increase CMRGlc with different rates. The various reports,
mainly from brain imaging and spectroscopy methods, contribute to a
better understanding of brain functions at rest and during neural activa-
tion, but also paint a complex picture that is complicated to quantita-
tively estimate.
It is important to stress that although the above considerations
imply a transient mismatch in CMRGlc and CMRO2, this does not imply
an uncoupling of glucose and oxygen metabolism. Rather these events
are likely coordinated, as Glu is an integrated element of the malate–
aspartate shuttle (McKenna et al., 2006), critical in regulating cytosolic
redox potential. In other words, we propose that, in order to achieve
the new metabolic steady state, glycolysis must transiently increase
above CMRO2, which is most likely the result of coupled metabolic
events. However, the conclusion by Mangia et al. (2007a), namely that
activation is primarily powered by increased ATP production produced
by oxidative metabolism, is maintained.
We conclude that this study reports lactate and glutamate increases
in the motor cortex, which reached a new steady state after 1–2 min of
activation. The observed metabolite changes were similar to those re-
ported in previous studies in the visual cortex at high ﬁeld (Lin et al.,
2012; Mangia et al., 2007a; Schaller et al., 2013). We also infer that
the small but signiﬁcant increases in Glu and Lac are most likely a gen-
eralmanifestation of neuronal activation powered at steady-statemain-
ly by oxidative metabolism. However, initially an increase in ΔCMRO2
that is transiently below that of ΔCMRGlc in the ﬁrst 1–2 min of activa-
tion is stipulated.Acknowledgments
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